293 related articles for article (PubMed ID: 15240595)
1. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules.
Finley DJ; Arora N; Zhu B; Gallagher L; Fahey TJ
J Clin Endocrinol Metab; 2004 Jul; 89(7):3214-23. PubMed ID: 15240595
[TBL] [Abstract][Full Text] [Related]
2. Discrimination of benign and malignant thyroid nodules by molecular profiling.
Finley DJ; Zhu B; Barden CB; Fahey TJ
Ann Surg; 2004 Sep; 240(3):425-36; discussion 436-7. PubMed ID: 15319714
[TBL] [Abstract][Full Text] [Related]
3. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression.
Rosen J; He M; Umbricht C; Alexander HR; Dackiw AP; Zeiger MA; Libutti SK
Surgery; 2005 Dec; 138(6):1050-6; discussion 1056-7. PubMed ID: 16360390
[TBL] [Abstract][Full Text] [Related]
4. Advancing the molecular diagnosis of thyroid nodules: defining benign lesions by molecular profiling.
Finley DJ; Lubitz CC; Wei C; Zhu B; Fahey TJ
Thyroid; 2005 Jun; 15(6):562-8. PubMed ID: 16029122
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
6. Meta- and reanalysis of gene expression profiles of hot and cold thyroid nodules and papillary thyroid carcinoma for gene groups.
Eszlinger M; Wiench M; Jarzab B; Krohn K; Beck M; Läuter J; Gubała E; Fujarewicz K; Swierniak A; Paschke R
J Clin Endocrinol Metab; 2006 May; 91(5):1934-42. PubMed ID: 16407496
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
Abd-El Raouf SM; Ibrahim TR
Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
[TBL] [Abstract][Full Text] [Related]
8. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings.
Sapio MR; Posca D; Raggioli A; Guerra A; Marotta V; Deandrea M; Motta M; Limone PP; Troncone G; Caleo A; Rossi G; Fenzi G; Vitale M
Clin Endocrinol (Oxf); 2007 May; 66(5):678-83. PubMed ID: 17381488
[TBL] [Abstract][Full Text] [Related]
9. Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.
Batista FA; Ward LS; Marcello MA; Martins MB; Peres KC; Torricelli C; Bufalo NE; Soares FA; da Silva MJ; Assumpção LV
J Endocrinol Invest; 2016 Apr; 39(4):423-9. PubMed ID: 26370671
[TBL] [Abstract][Full Text] [Related]
10. Classification of follicular thyroid tumors by molecular signature: results of gene profiling.
Barden CB; Shister KW; Zhu B; Guiter G; Greenblatt DY; Zeiger MA; Fahey TJ
Clin Cancer Res; 2003 May; 9(5):1792-800. PubMed ID: 12738736
[TBL] [Abstract][Full Text] [Related]
11. Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions.
Mostoufi-Moab S; Labourier E; Sullivan L; LiVolsi V; Li Y; Xiao R; Beaudenon-Huibregtse S; Kazahaya K; Adzick NS; Baloch Z; Bauer AJ
Thyroid; 2018 Jan; 28(1):60-67. PubMed ID: 29108474
[TBL] [Abstract][Full Text] [Related]
12. Genetic markers differentiating follicular thyroid carcinoma from benign lesions.
Freitas BC; Cerutti JM
Mol Cell Endocrinol; 2010 May; 321(1):77-85. PubMed ID: 19932149
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L
Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935
[TBL] [Abstract][Full Text] [Related]
14. CITED1 protein expression suggests Papillary Thyroid Carcinoma in high throughput tissue microarray-based study.
Prasad ML; Pellegata NS; Kloos RT; Barbacioru C; Huang Y; de la Chapelle A
Thyroid; 2004 Mar; 14(3):169-75. PubMed ID: 15072698
[TBL] [Abstract][Full Text] [Related]
15. Microarray analysis refines classification of non-medullary thyroid tumours of uncertain malignancy.
Fontaine JF; Mirebeau-Prunier D; Franc B; Triau S; Rodien P; Houlgatte R; Malthièry Y; Savagner F
Oncogene; 2008 Apr; 27(15):2228-36. PubMed ID: 17968324
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.
Yu S; Liu Y; Wang J; Guo Z; Zhang Q; Yu F; Zhang Y; Huang K; Li Y; Song E; Zheng XL; Xiao H
J Clin Endocrinol Metab; 2012 Jun; 97(6):2084-92. PubMed ID: 22472564
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
18. Molecular classification of thyroid nodules by cytology.
Pagedar NA; Chen DH; Wasman JK; Savvides P; Schluchter MD; Wilhelm SM; Lavertu P
Laryngoscope; 2008 Apr; 118(4):692-6. PubMed ID: 18094649
[TBL] [Abstract][Full Text] [Related]
19. RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint.
Marotta V; Guerra A; Sapio MR; Vitale M
Eur J Endocrinol; 2011 Oct; 165(4):499-507. PubMed ID: 21750045
[TBL] [Abstract][Full Text] [Related]
20. Identification of borderline thyroid tumors by gene expression array analysis.
Arora N; Scognamiglio T; Lubitz CC; Moo TA; Kato MA; Zhu B; Zarnegar R; Chen YT; Fahey TJ
Cancer; 2009 Dec; 115(23):5421-31. PubMed ID: 19658182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
